GO:0042254 ribosome biogenesis: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042254 ribosome biogenesis is the cellular process that builds ribosomal subunits, including rRNA processing, ribosomal protein assembly, and transport to sites of protein synthesis.
• Ribosome biogenesis is tightly coupled to cell growth, proliferation, and stress responses, and its dysregulation is a hallmark of cancer and developmental disorders.
• Key genes include ribosomal protein genes (e.g., RPS6, RPL5), rRNA processing factors (e.g., UTPs, EXOSC members), and assembly chaperones (e.g., NPM1, RIOK2).
• Alterations in ribosome biogenesis drive cancer metastasis, therapeutic resistance, and ribosomopathies such as Diamond-Blackfan anemia.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of ribosome biogenesis gene function.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate ribosome biogenesis research.
Description
Ribosome biogenesis (GO:0042254) is a fundamental biological process that produces the macromolecular machines responsible for protein synthesis. It encompasses the transcription and processing of ribosomal RNA (rRNA), the assembly of ribosomal proteins with rRNA, and the transport of nascent ribosomal subunits to the cytoplasm. This process is essential for cell growth and proliferation, and its dysregulation is increasingly linked to human diseases, including cancer and ribosomopathies. Researchers study ribosome biogenesis to understand how cells coordinate growth signals with protein production capacity, and to identify therapeutic targets. The complexity of ribosome biogenesis, involving hundreds of assembly factors and small nucleolar RNAs, makes it a rich area for functional genomics and CRISPR-based screens.
ribosome biogenesis At A Glance
| GO ID | GO:0042254 |
|---|---|
| GO term | ribosome biogenesis |
| Ontology | biological_process |
| Synonym | ribosome biogenesis and assembly |
| Major function | Biosynthesis, assembly, and transport of ribosomal subunits |
| Key cellular location | Nucleolus, nucleoplasm, cytoplasm |
| Major regulators | mTOR signaling, MYC, p53, ribosome assembly factors |
| Disease relevance | Cancer, ribosomopathies, developmental disorders |
What Is GO:0042254?
According to the Gene Ontology, ribosome biogenesis (GO:0042254) is a cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of ribosome subunits; it includes transport to the sites of protein synthesis. In simpler terms, it is the entire pathway that builds ribosomes, from making rRNA and ribosomal proteins to assembling them into functional subunits and delivering them where translation occurs.
Why Is ribosome biogenesis Important in Cell Biology?
Ribosome biogenesis is critical because it determines the cell's capacity for protein synthesis, which is directly linked to cell growth, proliferation, and survival. Dysregulation of this process is a common feature of cancer cells, which often exhibit increased ribosome production to support rapid growth. Moreover, mutations in ribosome biogenesis factors cause a class of diseases known as ribosomopathies, such as Diamond-Blackfan anemia and Shwachman-Diamond syndrome. Understanding ribosome biogenesis provides insights into fundamental cell biology and offers opportunities for therapeutic intervention in cancer and other diseases.
• Controls protein synthesis capacity and cell growth.
• Dysregulated in many cancers, supporting proliferation and metastasis.
• Mutations cause ribosomopathies, including Diamond-Blackfan anemia.
• Integrates growth signaling pathways such as mTOR and MYC.
• Target for cancer therapeutics, including rRNA synthesis inhibitors.
• Essential for normal development and tissue homeostasis.
• Involved in stress responses and p53 activation.
• Provides biomarkers for cancer diagnosis and prognosis.
• Enables high-throughput CRISPR screens to identify new regulators.
• Offers opportunities for RNA-based and small-molecule therapies.
What Happens During ribosome biogenesis?
rRNA transcription and processing
In simple terms: The cell first makes a long rRNA transcript and then cuts it into smaller pieces.
Ribosome biogenesis begins with the transcription of ribosomal DNA (rDNA) by RNA polymerase I to produce a large precursor rRNA (47S in humans). This precursor is processed through a series of cleavages and modifications guided by small nucleolar RNAs (snoRNAs) to yield mature 18S, 5.8S, and 28S rRNAs. RNA polymerase III transcribes 5S rRNA, which is incorporated into the large subunit. Processing occurs in the nucleolus and requires numerous assembly factors and exonucleases.
Ribosomal protein synthesis and import
In simple terms: Ribosomal proteins are made in the cytoplasm and then moved into the nucleus.
Ribosomal proteins are transcribed by RNA polymerase II, translated in the cytoplasm, and then imported into the nucleus and targeted to the nucleolus. Many ribosomal proteins also have extra-ribosomal functions, and their stoichiometry is tightly regulated. Importin proteins mediate nuclear import, and defects in this step can lead to ribosomopathies.
Assembly of pre-ribosomal subunits
In simple terms: rRNA and ribosomal proteins are put together like a puzzle to form two subunits.
In the nucleolus, pre-40S and pre-60S subunits assemble with the help of assembly factors, including GTPases, ATPases, and chaperones. These factors ensure correct folding and modification of rRNA and prevent premature export. The assembly process is highly dynamic and involves sequential addition and removal of factors.
Nuclear export and cytoplasmic maturation
In simple terms: The nearly finished subunits are shipped out of the nucleus and finished in the cytoplasm.
Pre-ribosomal subunits are exported to the cytoplasm through nuclear pore complexes, where they undergo final maturation steps, including removal of remaining assembly factors and incorporation of some ribosomal proteins. Cytoplasmic maturation is required for translational competence. Quality control pathways monitor assembly and degrade defective subunits.
Regulation by growth signaling
In simple terms: The cell decides how many ribosomes to make based on growth signals.
Ribosome biogenesis is regulated by nutrient and growth factor signaling, primarily through the mTOR pathway, which controls rRNA transcription and processing. MYC oncogene amplifies ribosome biogenesis, while p53 can induce cell cycle arrest or apoptosis in response to ribosomal stress. This regulation ensures that ribosome production matches the cell's metabolic state.
Key Genes Involved in GO:0042254 ribosome biogenesis
The following genes encode key factors involved in ribosome biogenesis, including ribosomal proteins, rRNA processing factors, and assembly chaperones.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RPS6 | 40S ribosomal protein | Phosphorylation linked to growth signaling |
| RPL5 | 60S ribosomal protein | Mutated in Diamond-Blackfan anemia |
| RPL11 | 60S ribosomal protein | Inhibits MDM2, activates p53 |
| NPM1 | Chaperone for ribosome assembly | Mutated in leukemia |
| RIOK2 | Kinase involved in 40S assembly | Required for ribosome maturation |
| UTP4 | Component of UTP-B complex | Mutated in North American Indian childhood cirrhosis |
| EXOSC3 | Exosome component for rRNA processing | Mutations cause pontocerebellar hypoplasia |
| MYC | Transcription factor | Amplifies ribosome biogenesis in cancer |
| MTOR | Kinase regulating growth | Controls rRNA transcription |
| TP53 | Tumor suppressor | Responds to ribosomal stress |
| RPS19 | 40S ribosomal protein | Most commonly mutated in DBA |
| RPL10 | 60S ribosomal protein | Mutated in X-linked DBA |
| SBDS | Assembly factor | Mutated in Shwachman-Diamond syndrome |
| DKC1 | Pseudouridine synthase | Mutated in dyskeratosis congenita |
| POLR1A | RNA polymerase I subunit | Transcribes rRNA |
| POLR1B | RNA polymerase I subunit | Transcribes rRNA |
| FBL | Fibrillarin, rRNA methyltransferase | Modifies rRNA |
How Is ribosome biogenesis Regulated?
Ribosome biogenesis is regulated at multiple levels, including transcription of rRNA by RNA polymerase I, processing of pre-rRNA, and assembly of ribosomal proteins. The mTOR signaling pathway promotes ribosome biogenesis by activating rRNA transcription and translation of ribosomal proteins in response to nutrients and growth factors. MYC oncogene directly stimulates the expression of many ribosome biogenesis genes, while p53 can be activated by ribosomal stress to induce cell cycle arrest or apoptosis. Additionally, the integrated stress response can inhibit translation initiation, indirectly affecting ribosome biogenesis.
ribosome biogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RPS19 | Diamond-Blackfan anemia | Knockout or point mutation in hematopoietic cells |
| SBDS | Shwachman-Diamond syndrome | Knock-in of patient mutations in iPSCs |
| MYC | Cancer (multiple types) | Overexpression in cancer cell lines |
| TP53 | Ribosomal stress response | Knockout to study p53 activation |
| EXOSC3 | Pontocerebellar hypoplasia | Knockout in neuronal models |
Ribosome biogenesis in cancer
Cancer cells often exhibit increased ribosome biogenesis to support rapid proliferation and protein synthesis. Oncogenes such as MYC amplify rRNA transcription, while tumor suppressors like p53 monitor ribosomal stress. Alterations in ribosome biogenesis contribute to metastasis and therapeutic resistance, making it a promising target for cancer therapy.
Ribosomopathies
Ribosomopathies are a group of disorders caused by mutations in ribosome biogenesis factors, leading to tissue-specific defects. Examples include Diamond-Blackfan anemia (mutations in RPS19, RPL5, RPL11), Shwachman-Diamond syndrome (SBDS), and dyskeratosis congenita (DKC1). These diseases highlight the importance of ribosome biogenesis in development and tissue homeostasis.
Neurodevelopmental disorders
Mutations in rRNA processing factors such as EXOSC3 cause pontocerebellar hypoplasia, a severe neurodevelopmental disorder. Defects in ribosome biogenesis can lead to impaired translation in neurons, which are particularly sensitive to protein synthesis defects.
From ribosome biogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate rRNA processing? | CRISPR knockout in HeLa or HEK293 cells |
| Does mutation Y cause ribosomopathy? | Point mutation knock-in in iPSCs |
| Can overexpression of gene Z drive cancer? | Overexpression in cancer cell lines |
| What is the interactome of assembly factor A? | Tagged knock-in for affinity purification |
| Which genes are essential for ribosome biogenesis? | Genome-wide CRISPR library screening |
| How does mTOR regulate ribosome biogenesis? | Knockout of mTOR or raptor in cell lines |
How to Study the ribosome biogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Translation efficiency and ribosome occupancy | Global translation profiling |
| RNA-seq | rRNA processing intermediates and mRNA levels | Quantify ribosome biogenesis gene expression |
| Proteomics | Protein abundance and interactions | Identify assembly factors |
| Fluorescence microscopy | Nucleolar morphology and factor localization | Visualize ribosome biogenesis |
| CRISPR knockout screens | Gene essentiality | Discover new ribosome biogenesis regulators |
| Polysome profiling | Ribosome assembly state | Assess translation initiation |
| Northern blot | rRNA processing intermediates | Validate rRNA processing defects |
Ribo-seq and RNA-seq
Ribosome profiling (Ribo-seq) measures translation efficiency and ribosome occupancy, providing insights into ribosome biogenesis and function. RNA-seq can quantify rRNA processing intermediates and ribosomal protein mRNA levels. These methods are used to study how perturbations affect ribosome biogenesis.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify assembly factors and ribosomal proteins associated with pre-ribosomal particles. Affinity purification of tagged assembly factors followed by mass spectrometry reveals dynamic interactions during ribosome biogenesis.
Imaging and flow cytometry
Fluorescence microscopy can visualize nucleolar structure and ribosome biogenesis factors. Flow cytometry can measure cell cycle progression and proliferation, which are linked to ribosome biogenesis.
CRISPR screens
Genome-wide CRISPR knockout screens have identified essential genes for ribosome biogenesis and cell growth. These screens can be combined with drugs to find synthetic lethal interactions.
How CRISPR Can Be Used to Study GO:0042254 ribosome biogenesis
Knockout
CRISPR knockout of ribosome biogenesis genes can reveal their essentiality and impact on cell growth and translation. For example, knockout of RPS19 in hematopoietic cells models Diamond-Blackfan anemia. Knockout screens have identified numerous factors required for ribosome biogenesis.
Point Mutation
Point mutations in ribosome biogenesis genes, such as those found in ribosomopathies, can be introduced using CRISPR base editing or homology-directed repair. These models help dissect the molecular mechanisms of disease-associated mutations.
Knock-in
Knock-in of tags (e.g., GFP, HA) into endogenous ribosome biogenesis genes allows visualization and purification of assembly intermediates. Knock-in of patient-specific mutations in iPSCs provides disease models.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can drive increased expression of ribosome biogenesis genes, mimicking oncogenic states. Overexpression of MYC or ribosomal proteins can transform cells and is used to study cancer.
How EDITGENE Supports ribosome biogenesis Research
Researchers studying ribosome biogenesis-related genes often need to determine whether a candidate gene is causally involved in rRNA processing, ribosome assembly, or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic modifications in relevant cell models, accelerating functional validation and therapeutic discovery.
Contact EDITGENE today to design your custom CRISPR model for ribosome biogenesis research.
Frequently Asked Questions About ribosome biogenesis
What is ribosome biogenesis?
Ribosome biogenesis (GO:0042254) is the cellular process that builds ribosomal subunits, including rRNA processing, assembly with ribosomal proteins, and transport to the cytoplasm.
What genes are involved in ribosome biogenesis?
Key genes include ribosomal proteins (RPS6, RPL5), assembly factors (NPM1, RIOK2), rRNA processing factors (UTP4, EXOSC3), and regulators (MYC, MTOR).
Why is ribosome biogenesis important in cancer?
Cancer cells often increase ribosome biogenesis to support rapid growth, and its dysregulation contributes to metastasis and therapy resistance.
What diseases are linked to ribosome biogenesis defects?
Ribosomopathies such as Diamond-Blackfan anemia, Shwachman-Diamond syndrome, and dyskeratosis congenita are caused by mutations in ribosome biogenesis genes.
How is ribosome biogenesis regulated?
It is regulated by mTOR signaling, MYC, and p53 in response to nutrients, growth factors, and stress.
What methods are used to study ribosome biogenesis?
Common methods include Ribo-seq, RNA-seq, proteomics, fluorescence microscopy, and CRISPR screens.
Can CRISPR be used to study ribosome biogenesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional studies of ribosome biogenesis genes.
What is the role of rRNA processing in ribosome biogenesis?
rRNA processing converts precursor rRNA into mature 18S, 5.8S, and 28S rRNAs, a critical step in ribosome assembly.
Which ribosomal proteins are mutated in Diamond-Blackfan anemia?
RPS19, RPL5, RPL11, and RPL10 are among the most commonly mutated ribosomal protein genes in DBA.
How does EDITGENE support ribosome biogenesis research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to ribosome biogenesis studies.
Conclusion
Ribosome biogenesis (GO:0042254) is a central cellular process that sustains protein synthesis and cell growth, with profound implications for cancer and genetic diseases. Advances in CRISPR technology and functional genomics are accelerating the discovery of new regulators and therapeutic targets. EDITGENE offers comprehensive CRISPR services to support mechanistic and translational research in ribosome biogenesis, from single-gene knockout to genome-wide screens.
References
- 1. Dörner K et al.. 2023. Ribosome biogenesis factors-from names to functions.. EMBO J 42(7):e112699 PMID: 36762427
- 2. Ni C et al.. 2023. Ribosome biogenesis and function in development and disease.. Development 150(5) PMID: 36897354
- 3. Pelletier J et al.. 2018. Ribosome biogenesis in cancer: new players and therapeutic avenues.. Nat Rev Cancer 18(1):51-63 PMID: 29192214
- 4. Elhamamsy AR et al.. 2022. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.. Cancer Res 82(13):2344-2353 PMID: 35303060
- 5. Penzo M et al.. 2019. The Ribosome Biogenesis-Cancer Connection.. Cells 8(1) PMID: 30650663
- 6. Nait Slimane S et al.. 2020. Ribosome Biogenesis Alterations in Colorectal Cancer.. Cells 9(11) PMID: 33120992
- 7. Pecoraro A et al.. 2021. Ribosome Biogenesis and Cancer: Overview on Ribosomal Proteins.. Int J Mol Sci 22(11) PMID: 34071057
- 8. Catez F et al.. 2019. Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics.. Biochem Pharmacol 159:74-81 PMID: 30468711
